NASDAQ:SIENSientra Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sientra Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.84 -0.19 (-9.36 %) (As of 04/8/2020 04:02 AM ET) Add Compare Share Today's Range$1.81Now: $1.84▼$2.1550-Day Range$1.01MA: $3.17▼$6.1052-Week Range$1.00Now: $1.84▼$9.71Volume1.08 million shsAverage Volume909,521 shsMarket Capitalization$91.97 millionP/E RatioN/ADividend YieldN/ABeta1.23 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.Read More Beat the Market (BTM) Rank™ 4.5 Analyst's Opinion Consensus RatingSientra has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.92, Sientra has a potential upside of 330.3% from its current price of $1.84.Amount of Analyst CoverageSientra has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.2 Community Rank Outperform VotesSientra has received 249 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSientra has received 306 “underperform” votes. (Add your “underperform” vote.)Community SentimentSientra has received 55.14% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote “Outperform” if you believe SIEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSientra does not currently pay a dividend.Dividend GrowthSientra does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sientra insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $474,658.00 in company stock.Percentage Held by InsidersOnly 13.30% of the stock of Sientra is held by insiders.Percentage Held by Institutions85.25% of the stock of Sientra is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Sientra are expected to decrease by -23.27% in the coming year, from ($1.59) to ($1.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sientra is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sientra is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSientra has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.54 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SIEN Previous Symbol CUSIPN/A CIK1551693 Webhttp://www.sientra.com/ Phone805-562-3500Debt Debt-to-Equity Ratio0.47 Current Ratio2.23 Quick Ratio1.67Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$83.70 million Price / Sales1.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.65 per share Price / Book1.12Profitability EPS (Most Recent Fiscal Year)($2.29) Net Income$-106,820,000.00 Net Margins-131.32% Return on Equity-110.93% Return on Assets-44.22%Miscellaneous Employees259 Outstanding Shares49,985,000Market Cap$91.97 million Next Earnings Date5/13/2020 (Estimated) OptionableOptionable Receive SIEN News and Ratings via Email Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:SIEN Rates by TradingView Sientra (NASDAQ:SIEN) Frequently Asked Questions How has Sientra's stock been impacted by COVID-19 (Coronavirus)? Sientra's stock was trading at $2.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SIEN stock has decreased by 24.6% and is now trading at $1.84. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Sientra? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sientra. When is Sientra's next earnings date? Sientra is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Sientra. How were Sientra's earnings last quarter? Sientra Inc (NASDAQ:SIEN) released its earnings results on Wednesday, March, 11th. The medical instruments supplier reported ($0.41) EPS for the quarter, topping the Zacks' consensus estimate of ($0.42) by $0.01. The medical instruments supplier had revenue of $23.21 million for the quarter, compared to analysts' expectations of $23.20 million. Sientra had a negative net margin of 131.32% and a negative return on equity of 110.93%. View Sientra's earnings history. What guidance has Sientra issued on next quarter's earnings? Sientra issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, March, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $94-98 million, compared to the consensus revenue estimate of $101.66 million. What price target have analysts set for SIEN? 7 brokers have issued 12-month price objectives for Sientra's shares. Their forecasts range from $5.00 to $10.00. On average, they anticipate Sientra's stock price to reach $7.92 in the next twelve months. This suggests a possible upside of 330.3% from the stock's current price. View analysts' price targets for Sientra. Has Sientra been receiving favorable news coverage? Headlines about SIEN stock have trended very negative on Wednesday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sientra earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutSientra. Are investors shorting Sientra? Sientra saw a increase in short interest in March. As of March 13th, there was short interest totaling 3,179,400 shares, an increase of 25.7% from the February 27th total of 2,530,000 shares. Based on an average trading volume of 1,031,900 shares, the short-interest ratio is currently 3.1 days. Currently, 7.3% of the shares of the company are sold short. View Sientra's Current Options Chain. Who are some of Sientra's key competitors? Some companies that are related to Sientra include Establishment Labs (ESTA), Invacare (IVC), Lakeland Industries (LAKE), RTI Surgical (RTIX), Allied Healthcare Products (AHPI), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Ocugen (OCGN) and Avitar (AVTI). What other stocks do shareholders of Sientra own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Opko Health (OPK), Alibaba Group (BABA), Oasis Petroleum (OAS), Verizon Communications (VZ), Baidu (BIDU), Idera Pharmaceuticals (IDRA) and Micron Technology (MU). Who are Sientra's key executives? Sientra's management team includes the following people: Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 61)Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin. What is Sientra's stock symbol? Sientra trades on the NASDAQ under the ticker symbol "SIEN." How do I buy shares of Sientra? Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sientra's stock price today? One share of SIEN stock can currently be purchased for approximately $1.84. How big of a company is Sientra? Sientra has a market capitalization of $91.97 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 259 workers across the globe. View additional information about Sientra. What is Sientra's official website? The official website for Sientra is http://www.sientra.com/. How can I contact Sientra? Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected] This page was last updated on 4/8/2020 by MarketBeat.com StaffFeatured Article: What is the NASDAQ Stock Market?
